tasimelteon and its Impurities

A selective agonist for the melatonin receptors MT1 and MT2, Tasimelteon is used in the treatment of insomnia and other sleep disorders. Reference standards of Tasimelteon API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 20 results for tasimelteon Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 47 16000

Tasimelteon

Tasimelteon


  • Catalogue No.:PA 47 16000

  • CAS :

    609799-22-6

  • Molecular Formula : C15H19NO2

  • Molecular Weight : 245.32

Drug Reference Standards & Impurity Synthesis in India
PA 47 16510

N-(((1S,2S)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide

N-(((1S,2S)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide


  • Catalogue No.:PA 47 16510

  • CAS :

    209255-72-1

  • Molecular Formula : C15H19NO2

  • Molecular Weight : 245.32

Drug Reference Standards & Impurity Synthesis in India
PA 47 16520

N-(((1R,2S)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide

N-(((1R,2S)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide


  • Catalogue No.:PA 47 16520

  • CAS :

    251562-65-9

  • Molecular Formula : C15H19NO2

  • Molecular Weight : 245.32

Drug Reference Standards & Impurity Synthesis in India
PA 47 16530

N-(((1S,2S)-2-(2,3-Dihydrobenzofuran-4-yl)-1-((2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)(propionamido)methyl)cyclopropyl)methyl)propionamide

N-(((1S,2S)-2-(2,3-Dihydrobenzofuran-4-yl)-1-((2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)(propionamido)methyl)cyclopropyl)methyl)propionamide


  • Catalogue No.:PA 47 16530

  • CAS :

    NA

  • Molecular Formula : C30H36N2O4

  • Molecular Weight : 488.63

Drug Reference Standards & Impurity Synthesis in India
PA 47 16540

2-Hydroxy-6-(2-(propionamidomethyl)cyclopropyl)phenethyl (2-(2-hydroxyethyl)-3-(2-(propionamidomethyl)cyclopropyl)phenyl) Carbonate

2-Hydroxy-6-(2-(propionamidomethyl)cyclopropyl)phenethyl (2-(2-hydroxyethyl)-3-(2-(propionamidomethyl)cyclopropyl)phenyl) Carbonate


  • Catalogue No.:PA 47 16540

  • CAS :

    1803286-24-9

  • Molecular Formula : C31H40N2O7

  • Molecular Weight : 552.67

Drug Reference Standards & Impurity Synthesis in India
PA 47 16550

N-(((1R,2R)-2-(3-Oxo-2,3-dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide

N-(((1R,2R)-2-(3-Oxo-2,3-dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide


  • Catalogue No.:PA 47 16550

  • CAS :

    1803286-27-2

  • Molecular Formula : C15H17NO3

  • Molecular Weight : 259.31

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161000

(1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropane-1-carboxamide

(1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropane-1-carboxamide


  • Catalogue No.:PA 47 0161000

  • CAS :

    1161417-63-5

  • Molecular Formula : C12H13NO2

  • Molecular Weight : 203.24

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161001

((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine Hydrochloride

((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine Hydrochloride


  • Catalogue No.:PA 47 0161001

  • CAS :

    1651831-37-6

  • Molecular Formula : C12H16ClNO

  • Molecular Weight : 225.72

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161002

N-(((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)acetamide

N-(((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)acetamide


  • Catalogue No.:PA 47 0161002

  • CAS :

    1439984-63-0

  • Molecular Formula : C14H17NO2

  • Molecular Weight : 231.3

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161003

N-(((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)Cyclopropyl)methyl)Pentanamide

N-(((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)Cyclopropyl)methyl)Pentanamide


  • Catalogue No.:PA 47 0161003

  • CAS :

    1803286-26-1

  • Molecular Formula : C17H23NO2

  • Molecular Weight : 273.38

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161004

1,3-Bis(((1R,2R)-2-(2,3-Dihydro benzofuran-4-yl)cyclopropyl)methyl)urea

1,3-Bis(((1R,2R)-2-(2,3-Dihydro benzofuran-4-yl)cyclopropyl)methyl)urea


  • Catalogue No.:PA 47 0161004

  • CAS :

    1803286-21-6

  • Molecular Formula : C25H28N2O3

  • Molecular Weight : 404.51

Drug Reference Standards & Impurity Synthesis in India
PA STI 089432

Tasimelteon-D5

Tasimelteon-D5


  • Catalogue No.:PA STI 089432

  • CAS :

    1962124-51-1

  • Molecular Formula : C15H14D5NO2

  • Molecular Weight : 250.35

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161005

(1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)-N-propionylcyclopropane-1-carboxamide

(1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)-N-propionylcyclopropane-1-carboxamide


  • Catalogue No.:PA 47 0161005

  • CAS :

    NA

  • Molecular Formula : C15H17NO3

  • Molecular Weight : 259.31

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161006

N-(((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)-N-propionylpropionamide

N-(((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)-N-propionylpropionamide


  • Catalogue No.:PA 47 0161006

  • CAS :

    NA

  • Molecular Formula : C18H23NO3

  • Molecular Weight : 301.39

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161007

bis(((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)amine

bis(((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)amine


  • Catalogue No.:PA 47 0161007

  • CAS :

    NA

  • Molecular Formula : C24H27NO2

  • Molecular Weight : 361.49

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161008

N-(((1S,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide

N-(((1S,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide


  • Catalogue No.:PA 47 0161008

  • CAS :

    NA

  • Molecular Formula : C15H19NO2

  • Molecular Weight : 245.32

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161009

N-(((1R,2R)-2-(Benzofuran-4-yl)cyclopropyl)methyl)propionamide

N-(((1R,2R)-2-(Benzofuran-4-yl)cyclopropyl)methyl)propionamide


  • Catalogue No.:PA 47 0161009

  • CAS :

    1803287-41-3

  • Molecular Formula : C15H17NO2

  • Molecular Weight : 243.31

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161010

rel-N-(((1R,2S)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)acetamide

rel-N-(((1R,2S)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)acetamide


  • Catalogue No.:PA 47 0161010

  • CAS :

    251562-66-0

  • Molecular Formula : C14H17NO2

  • Molecular Weight : 231.3

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161011

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-((4-((1R,2R)-2-(propionamidomethyl)cyclopropyl)-2,3-dihydrobenzofuran-2-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-((4-((1R,2R)-2-(propionamidomethyl)cyclopropyl)-2,3-dihydrobenzofuran-2-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid


  • Catalogue No.:PA 47 0161011

  • CAS :

    NA

  • Molecular Formula : C21H27NO9

  • Molecular Weight : 437.45

Drug Reference Standards & Impurity Synthesis in India
PA 47 0161012

N-(((1R,2R)-2-((S)-3-hydroxy-2,3-dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide

N-(((1R,2R)-2-((S)-3-hydroxy-2,3-dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide


  • Catalogue No.:PA 47 0161012

  • CAS :

    1448344-03-3

  • Molecular Formula : C15H19NO3

  • Molecular Weight : 261.32

pharmaffiliates